Medicine and Health
Spatial proteomics identifies JAKi as treatment for a lethal skin disease
T. M. Nordmann, H. Anderton, et al.
A groundbreaking study by Thierry M. Nordmann and colleagues reveals that targeting JAK inhibitors could be a transformative therapy for toxic epidermal necrolysis (TEN), a severe drug-induced skin reaction. Through deep visual proteomics analysis, the research identified key activation signatures in TEN, demonstrating the promise of JAK inhibitors in improving patient outcomes.
Related Publications
Explore these studies to deepen your understanding of the subject.

